Plasma-derived Factor VIII is produced by isolating the protein from donated plasma, rigorously purifying and inactivating viruses through advanced methods, and packaging it into sterile vials.
This complex process ensures a safe, injectable treatment for Hemophilia A patients. It transforms a vital blood component into a life-saving medicine. This aspect has been covered in this episode of Iran Tech.
This makes it easy to access the Press TV website